DR. DAVID A BAKER, MD
Osteopathic Medicine at 128 St, Kirkland, WA
License number
Washington MD00038802
Category
Osteopathic Medicine
Type
Emergency Medicine
License number
Washington MD00038802
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
12040 NE 128Th St #MS 105, Kirkland, WA 98034
PO Box 34036, Seattle, WA 98124
PO Box 34036, Seattle, WA 98124
Phone
(425) 899-2560
(425) 899-2079 (Fax)
(425) 899-3292
(425) 899-3269 (Fax)
(425) 899-2079 (Fax)
(425) 899-3292
(425) 899-3269 (Fax)
Organization information
See more information about DAVID A BAKER at bizstanding.comDavid Baker MD
325 9 Ave, Seattle, WA 98104
Industry:
Internist
Phone:
(206) 731-3000 (Phone)
David Andrew Baker
Professional information
Electrical Engineer At Electroimpact
Position:
Electrical Engineer at Electroimpact
Location:
Greater Seattle Area
Industry:
Electrical/Electronic Manufacturing
Work:
Electroimpact
- Mukilteo, WA since Jan 2010
-
Electrical Engineer
Wolf Robotics
- Fort Collins, Colorado Apr 2008 - Aug 2009
-
Electrical Controls Engineer
Micron
- Boise, Idaho Nov 2004 - Apr 2008
-
Process Engineer
LSI Logic
- Fort Collins, Colorado Area Aug 2000 - Sep 2001
-
Mask Designer
Celestica
- Fort Collins, Colorado Area Jan 1998 - Aug 2000
-
Repair Technician
Education:
Colorado State University 2000 - 2004
BSEE, Electrical Engineering Westwood College of Technology 2009 - 2010
TAAD, Architectural Drafting and Architectural CAD/CADD
BSEE, Electrical Engineering Westwood College of Technology 2009 - 2010
TAAD, Architectural Drafting and Architectural CAD/CADD
Skills:
Manufacturing, Electrical Engineering, Automation, Schematic, Troubleshooting, Soldering, Electronics, AutoCAD
Deputy Prosecuting Attorney
Position:
Deputy Prosecuting Attorney at King County Prosecuting Attorney's Office
Location:
Greater Seattle Area
Industry:
Law Practice
Work:
King County Prosecuting Attorney's Office
since Nov 2009
-
Deputy Prosecuting Attorney
King County Prosecuting Attorney's Office
Jun 2008 - May 2009
-
Rule 9 Legal Intern
Mills Meyers Swartling
2005 - 2006
-
Office Assistant
American Marine Bank
2002 - 2005
-
Customer Service Teller
Education:
Seattle University School of Law 2006 - 2009
JD University of Washington 2001 - 2005
BA, Political Science and Economics
JD University of Washington 2001 - 2005
BA, Political Science and Economics
Skills:
Criminal Law, Criminal Prosecution, Legal Writing, Trials
Vice President At Eagle Home Mortgage
Position:
Vice President at Eagle Home Mortgage
Location:
Greater Seattle Area
Industry:
Financial Services
Work:
Eagle Home Mortgage
-
Vice President
Manager At Boeing - Eo&Amp;T
Position:
Manager at Boeing - EO&T
Location:
Greater Seattle Area
Industry:
Aviation & Aerospace
Work:
Boeing - EO&T
-
Manager
Polypeptides For Treating And/Or Limiting Influenza Infection
US Patent:
2013014, Jun 6, 2013
Filed:
Aug 3, 2011
Appl. No.:
13/813356
Inventors:
David Baker - Seattle WA, US
Timothy A. Whitehead - East Grand Rapids MI, US
Sarel Fleishman - Rehovot, IL
Timothy A. Whitehead - East Grand Rapids MI, US
Sarel Fleishman - Rehovot, IL
Assignee:
University of Washington through its Center for Commercialization - Seattle WA
International Classification:
C07K 14/00
US Classification:
514 37, 530350, 536 231, 4353201, 5303879, 435 5, 436501, 435325, 4352523
Abstract:
The present invention provides polypeptides according to the general formulas disclosed herein, which recognize and are strong binders to Influenza A hemagglutinin and can be used, for example, to treat and/or limit development of an influenza infection. The present invention further provides isolated nucleic acids encoding the polypeptides of the invention, recombinant expression vectors comprising the nucleic acids encoding the polypeptides of the invention operatively linked to a suitable control sequence, and recombinant host cells comprising the recombinant expression vectors of the invention. The present invention also provides antibodies that selectively bind to the polypeptides of the invention, and pharmaceutical compositions comprising one or more polypeptides according to the invention and a pharmaceutically acceptable carrier. Additionally, the present invention provides methods for treating and/or limiting an influenza infection, methods for diagnosing an influenza infection, or monitoring progression of an influenza infection, methods for identifying candidate influenza vaccines, and methods for identifying candidate compounds for treating, limiting, and/or diagnosing influenza infection.
Systems And Methods For Biotransformation Of Carbon Dioxide Into Higher Carbon Compounds
US Patent:
2013019, Aug 1, 2013
Filed:
Sep 15, 2011
Appl. No.:
13/823941
Inventors:
Justin Siegel - Davis CA, US
David Baker - Seattle WA, US
Amanda Lee Smith - Seattle WA, US
Mary E. Lidstrom - Seattle WA, US
Catherine Louw - Bellevue WA, US
David Baker - Seattle WA, US
Amanda Lee Smith - Seattle WA, US
Mary E. Lidstrom - Seattle WA, US
Catherine Louw - Bellevue WA, US
Assignee:
University of Washington through its Center for Commercialization - Seattle WA
International Classification:
C12N 9/88
US Classification:
435 26, 435150, 435232, 536 232, 4353201, 43525233, 435147, 43525421
Abstract:
Systems, compounds and methods for the conversion of C1 carbon compounds to higher carbon compounds useful for the generation of commodity compounds.
Epitope-Transplant Scaffolds And Their Use
US Patent:
2010006, Mar 18, 2010
Filed:
Aug 24, 2007
Appl. No.:
12/438913
Inventors:
Peter D. Kwong - Washington DC, US
Gilad Ofek - Washington DC, US
Javier Guenaga - Washington DC, US
Richard Wyatt - Rockville MD, US
Zhi-yong Yang - Potomac MD, US
Tongqing Zhou - Boyds MD, US
Gary J Nabel - Washington DC, US
Min Tang - N. Potomac MD, US
William Schief - Seattle WA, US
David Baker - Seattle WA, US
Gilad Ofek - Washington DC, US
Javier Guenaga - Washington DC, US
Richard Wyatt - Rockville MD, US
Zhi-yong Yang - Potomac MD, US
Tongqing Zhou - Boyds MD, US
Gary J Nabel - Washington DC, US
Min Tang - N. Potomac MD, US
William Schief - Seattle WA, US
David Baker - Seattle WA, US
International Classification:
A61K 39/00, G06G 7/58, C07K 14/00, C07H 21/04, G01N 33/53, A61P 31/18
US Classification:
4241851, 703 11, 530350, 536 231, 435 71
Abstract:
Computational protocols for the design of epitope-protein scaffolds which elicit selected neutralizing antibodies are disclosed, and related compositions and uses.
Monomeric Red Fluorescent Proteins
US Patent:
7671185, Mar 2, 2010
Filed:
May 15, 2007
Appl. No.:
11/748641
Inventors:
Benjamin S. Glick - Chicago IL, US
Brooke Bevis - Somerville MA, US
Daniel E. Strongin - Chicago IL, US
David Baker - Seattle WA, US
Michelle Scalley-Kim - Seattle WA, US
Brooke Bevis - Somerville MA, US
Daniel E. Strongin - Chicago IL, US
David Baker - Seattle WA, US
Michelle Scalley-Kim - Seattle WA, US
Assignee:
The University of Chicago - Chicago IL
The University of Washington - Seattle WA
The University of Washington - Seattle WA
International Classification:
C07H 21/04, A61K 38/00
US Classification:
536 231, 435440, 435 691, 530350
Abstract:
Disclosed are nucleotide sequences encoding monomeric variants of DsRed fluorescent proteins and methods of use thereof.
Monomeric Red Fluorescent Proteins
US Patent:
7910714, Mar 22, 2011
Filed:
Jan 19, 2010
Appl. No.:
12/689276
Inventors:
Benjamin S. Glick - Chicago IL, US
Brooke Bevis - Somerville MA, US
Daniel E. Strongin - Chicago IL, US
David Baker - Seattle WA, US
Michelle Scalley-Kim - Seattle WA, US
Brooke Bevis - Somerville MA, US
Daniel E. Strongin - Chicago IL, US
David Baker - Seattle WA, US
Michelle Scalley-Kim - Seattle WA, US
Assignee:
The University of Chicago - Chicago IL
The University of Washington - Seattle WA
The University of Washington - Seattle WA
International Classification:
C07H 21/04, A61K 38/00
US Classification:
536 231, 435440, 4351721, 530350
Abstract:
Disclosed are sequences encoding monomeric variants of DsRed fluorescent proteins and methods of use.
David Aleksander Baker, Seattle WA - Lawyer
Address:
516 3Rd Ave, Seattle 98104
(206) 477-1070
(206) 477-1070
Licenses:
Washington - Active 2009